Yzybio
Wuhan, CN · 1 known investors
Wuhan YZY Biopharma is a biotechnology company developing bispecific antibody (BsAb) therapies to treat cancer, cancer-related complications, and age-related ophthalmic diseases. It also develops preventive and therapeutic vaccines, including Y2019, a recombinant SARS-CoV-2 subunit protein vaccine developed with the Wuhan Institute of Virology.
Investors · 1
Frequently asked questions
- What does Yzybio do?
- Wuhan YZY Biopharma is a biotechnology company developing bispecific antibody (BsAb) therapies to treat cancer, cancer-related complications, and age-related ophthalmic diseases. It also develops preventive and therapeutic vaccines, including Y2019, a recombinant SARS-CoV-2 subunit protein vaccine developed with the Wuhan Institute of Virology.
- Who are Yzybio's investors?
- Yzybio's investors include Pan-Lin Capital.
- Where is Yzybio headquartered?
- Yzybio is headquartered in Wuhan, CN.